BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and Risk of Parkinson's Disease. J Parkinsons Dis 2021;11:31-43. [PMID: 33361610 DOI: 10.3233/JPD-202279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding Y, Li Y, Chhetri G, Peng X, Wu J, Wang Z, Zhao B, Zhao W, Li X. Parkinson's Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus Spread. Cells 2021;10:746. [PMID: 33800686 DOI: 10.3390/cells10040746] [Reference Citation Analysis]
2 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nakamura M, Ura S, Yabe I, Otsuki M, Soma H, Ogata A. Cat Scratch Disease-associated Encephalitis Followed by Parkinsonism: A Case Report. Intern Med . [DOI: 10.2169/internalmedicine.9047-21] [Reference Citation Analysis]
4 Franco R, Rivas-Santisteban R, Navarro G, Pinna A, Reyes-Resina I. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage. Int J Mol Sci 2021;22:4643. [PMID: 33924963 DOI: 10.3390/ijms22094643] [Reference Citation Analysis]
5 Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol 2021. [PMID: 34694344 DOI: 10.1001/jamaneurol.2021.3895] [Reference Citation Analysis]
6 Niklasson B, Lindquist L, Klitz W, Fredrikson S, Morgell R, Mohammadi R, Karapetyan Y, Englund E; Netherlands Brain Bank. Picornavirus May Be Linked to Parkinson’s Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra. Microorganisms 2022;10:599. [DOI: 10.3390/microorganisms10030599] [Reference Citation Analysis]
7 Hong X, Guo W, Li S, Laranjo M. Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson’s Disease: A Meta-Analysis and Systematic Review. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/9773038] [Reference Citation Analysis]
8 Kasen A, Houck C, Burmeister AR, Sha Q, Brundin L, Brundin P. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr Virus and Neurological Diseases. Front Mol Biosci 2022;8:816098. [DOI: 10.3389/fmolb.2021.816098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Anghelescu A, Onose G, Popescu C, Băilă M, Stoica S, Postoiu R, Brumă E, Petcu I, Ciobanu V, Munteanu C. Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment. Biomedicines 2022;10:1000. [DOI: 10.3390/biomedicines10051000] [Reference Citation Analysis]
11 Mamais A, Kaganovich A, Harvey K. Convergence of signalling pathways in innate immune responses and genetic formof Parkinson’s disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105721] [Reference Citation Analysis]